Evolving Role of Surgical Resection in Pancreatic Cancer

Dear Colleagues,

Surgical resection remains the cornerstone of curative-intent treatment for pancreatic cancer, yet its role continues to evolve in the context of improved systemic therapies, advanced imaging, and refined surgical techniques. This Special Issue will provide a comprehensive and contemporary overview of surgical resection in pancreatic cancer, with a focus on indications, operative strategies, and prognostic implications.

Topics of interest include patient selection and staging, the management of borderline resectable and locally advanced disease, vascular resection and reconstruction, minimally invasive and robotic approaches, and the integration of surgery into neoadjuvant and adjuvant therapies. This Special Issue will also address perioperative outcomes, oncologic results, quality of life, and emerging biomarkers to guide surgical decision-making.

By bringing together original research, reviews, and expert perspectives, this Special Issue will highlight evidence-based advances, ongoing debates, and future directions in pancreatic cancer surgery, ultimately aiming to optimize patient outcomes through multidisciplinary and technically sound surgical care.

Dr. Eran Sadot
Guest Editor

Dr. Oran Zlotnik
Dr. Nasser Abdul Halim
Guest Editor Assistants

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.